Pre-emption of Generic Drug Suits Mulled by Superior Court

If all brand-name pharmaceutical manufacturers withdraw from the market and only generic drugmakers are left, does that mean "plaintiffs who are injured can sue no one"? a Superior Court judge asked Wednesday during an oral argument session in Philadelphia.

This article requires free registration

This article requires free registration to The Legal Intelligencer. Please sign in or register to read the full text.